biomedicina slovenica


"Drug interaction" : 248

  1. Savšek Lina
    Zdravljenje multiple skleroze z monoklonskimi protitelesi: obvladovanje tveganj
    [Monoclonal antibodies in multiple sclerosis: risk management]
    2021
  2. Štuhec Matej; Flegar Ines; Zelko Erika; Kovačič Alenka; Zabavnik Valerija
    Clinical pharmacist interventions in cardiovascular disease pharmacotherapy in elderly patients on excessive polypharmacy
    2021
  3. Bajželj Matija; Anderluh Marko
    Sistematični pregled in napoved toksičnosti potencialnih učinkovin za zdravljenje COVID-19
    [Systematic review and toxicity prediction of potential COVID-19 drugs]
    2020
  4. Zeitlinger Markus; Koch Birgit C. P.; Bruggemann Roger; De Cock Pieter; Felton Timothy; Hites Maya; Le Jennifer; Luque Sonia; MacGowan Alasdair P.; Marriott Deborah J. E.; Nadrah Kristina
    Pharmacokinetics/pharmacodynamics of antiviral agents used to treat SARS-CoV-2 and their potential interaction with drugs and other supportive measures
    2020
  5. Knez Lea
    Interakcije med zdravili pri bolnikih z okvaro jeter
    [Drug interactions in patients with liver diseases]
    2019
  6. Wouden Cathelijne H.; Böhringer Stefan; Cecchin Erika; Cheung Ka-Chun; Dávila-Fajardo Cristina Lucía; Deneer Vera H.; Dolžan Vita; Ingelman-Sundberg Magnus; Jönsson Siv; Karlsson Mats O.
    Generating evidence for precision medicine
    2020
  7. Štuhec Matej; Potočin Ines; Stepan Dora; Ušaj Lea; Petek Šter Marija; Beović Bojana
    Potential drug interactions with antibacterials in long-term care facilities analyzed by two interaction checkers
    2019
  8. Kastelic Andrej
    Drug related risks of drug use and OST
    2017
  9. Kastrin Andrej; Ferk Polonca; Leskošek Branimir
    Predicting potential drug-drug interactions on topological and semantic similarity features using statistical learning
    2018
  10. Jakopin Žiga
    Vpliv kajenja na zdravilne učinkovine
    [The effect of smoking on drugs]
    2018
  11. Peterlin-Mašič Lucija
    Alkohol in zdravila
    [Alcohol and medicines]
    2018
  12. Muhič Neža; Mrhar Aleš; Brvar Miran
    Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions
    2017
  13. Štuhec Matej
    Pregled zdravil za zdravljenje motnje pozornosti s hiperaktivnostjo
    [A review of medications used in the treatment of attention deficit hyperactivity disorder]
    2013
  14. Štuhec Matej; Brunec Sara; Švab Vesna
    A retrospective study of drug-drug interactions in patients treated with pharmacotherapy in the biggest Slovenian correctional facility
    2017
  15. Štuhec Matej; Potočin Ines; Stepan Dora; Ušaj Lea; Petek Šter Marija; Beović Bojana
    Drug-drug interactions between antibiotics and psychopharmaceuticals in Slovenian nursing homes
    2017
  16. Režen Tadeja; Hafner Mateja; Kortagere Sandhya; Ekins Sean; Hodnik Vesna; Rozman Damjana
    Rosuvastatin and atorvastatin are ligands of the human CAR/RXR[alpha] complex
    2017
  17. Premuš Marušič Alenka; Petrovič Danijel; Mrhar Aleš; Locatelli Igor
    Polypharmacotherapy and blood products as risk factors for venous thromboembolism in postsurgical patients
    2017
  18. Frelih Aljoša; Gams Polona; Brvar Miran
    Neželeni učinki zaradi medsebojnega delovanja zdravil
    2015
  19. Sepčić Juraj; Bučuk Mira; Perković Olivio; Šepić-Grahovac Dubravka; Trošelj Vukić Biserka; Poljak Ivica; Crnić-Martinović Marija; Turel Iztok; Ristić Smiljana; Sepčić Kristina
    Drug-induced aseptic meningitis, sensorineural hearing loss and vestibulopaty
    2010
  20. Roblek Tina; Detiček Andreja; Leskovar Boštjan; Šuškovič Stanislav; Horvat Matej; Belič Aleš; Mrhar Aleš; Lainščak Mitja
    Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure
    2016
  21. Muhič Neža; Brvar Miran; Mrhar Aleš
    Napovedna vrednost podatkovnih baz za prepoznavanje neželenih učinkov zdravil zaradi interakcij
    2015
  22. Čebron Lipovec Nanča; Toni Janez; Svetina-Šorli Petra; Košnik Mitja
    Drug interaction in tuberculosis treatment - The role of pharmacists
    2012
  23. Drofenik Polonca
    Zdravljenje z varfarinom
    2009
  24. Virant Igor
    Klinično pomembne interakcije pri zdravljenju raka dojk
    2009
  25. Jezeršek Novaković Barbara; Mavri Alenka; Štalc Monika; Vene Nina; Boc Anja; Ostaševski Nina; Ježovnik Mateja; Gubenšek Mirjam; Tratar Gregor
    Predstavitev smernic za vodenje antikoagulacijskega zdravljenja pri onkoloških bolnikih z umetnimi srčnimi zaklopkami na sistemskem protitumorskem zdravljenju
    2009
  26. Sonc Monika
    Smernice pri onkoloških bolnikih, ki imajo z rakom povezano trombozo
    2009
  27. Čufar Andreja
    Aplikacija zdravil s hitrim delovanjem v nujni medicinski pomoči
    2011
  28. Jagodic Vilfan Alenka Helena
    Interakcije novih peroralnih antikoagulacijskih zdravil s hrano in z drugimi zdravili
    [Novel oral anticoagulants]
    2014
  29. Premuš Marušič Alenka
    Interakcije z zdravili za zdravljenje duševnih motenj
    [Drug Interactions with drugs used to treat mental disorders]
    2010
  30. Šoštarič Sabina; Cornu Pieter; Dupont Alain G.; Steurbaut Stephane; Mrhar Aleš
    Analiza avtomatskega sistema za spremljanje interkacij med zdravili
    [Analysis of the automated drug-drug interaction system]
    2014
  31. Premuš Marušič Alenka
    Sheme zdravljenja pri kronični bolečini in mehanizmi interakcij z analgetiki
    [Treatment alghoritms in chronic pain and mechanisms of interactions with analgesics]
    2012
  32. Janeš Damjan
    Samozdravljenje z zdravili naravnega izvora
    [Self-medication with herbal medicinal products]
    2011
  33. Kerec Kos Mojca
    Medsebojno delovanje zdravil brez recepta z drugimi zdravili
    [Drug-drug interactions of prescription free medicines]
    2011
  34. Trontelj Jurij
    Medsebojno delovanje zdravil pri starostnikih
    [Drug drug interactions in the elderly]
    2010
  35. Rožman Samo; Pečanac Olivera
    Hipotiroza in spremenjena biološka razpoložljivost levotiroksina
    2010
  36. Sonc Monika
    Farmakologija protitumorskih zdravil v sistemski terapiji zdravljenja raka s poudarkom na farmakokinetiki, farmakodinamiki in interakcijah
    2009
  37. Jenko Barbara; Lusa Lara; Tomšič Matija; Praprotnik Sonja; Logar Dušan; Dolžan Vita
    The influence of genetic variability in methotrexate transporters on toxicity in rheumatoid arthritis
    2013
  38. Goričar Katja; Kovač Viljem; Dolžan Vita
    The influence of polymorphisms in folate pathway genes on pemetrexed treatment outcome in malignant mesothelioma patients
    2013
  39. Drug metabolism and drug interactions
    1979
  40. Magdič Jožef
    Obravnava bolnikov z možgansko krvavitvijo zaradi protikoagulacijskega zdravljenja
    [Management of patients with anticoagulant treatment related brain haemorrhage]
    2012
  41. Sonc Monika
    Nujna zdravila za paliativno oskrbo
    2012
  42. Sonc Monika
    Vpliv varfarina na učinkovitost citotoksičnega zdravljenja
    2012
  43. Knez Lea; Kerec Kos Mojca; Čufer Tanja
    Drug interactions in cancer treatment
    2014
  44. Roblek Tina; Trobec Katja; Mrhar Aleš; Lainščak Mitja
    Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease
    2014
  45. Pal Marjetka; Ferk Polonca
    Interakcije zdravil z zaviralci angiotenzinske konvertaze
    [Drug interactions with angiotensin-converting enzyme inhibitors]
    2012
  46. Vasle Anže; Landekar Nina; Mrhar Aleš
    Analiza uporabnosti podatkovne baze Lexicomp za prepoznavanje potencialnih interakcij med zdravili
    [Analysis of usefulness of database Lexicomp for detecting potential drug-drug interactions]
    2014
  47. Kovačič Sašo; Premuš Marušič Alenka
    Klinični primer iz prakse kliničnega farmacevta - svetovalca
    [Clinical case example of a clinical pharmacist - consultant]
    2014
  48. Zakotnik Branko; Šorl Mihael
    Nevarna kombinacija tamoksifena in paroksetina
    2010
  49. Mencej Bedrač Simona; Zupan Janja; Jurković Mlakar Simona; Zavratnik Andrej; Preželj Janez; Marc Janja
    Raloxifene pharmacodynamics is influenced by genetic variants in the RANKL/RANK/OPG system and in the Wnt signaling pathway
    2014
  50. Šegrec Nuša
    Treating patient with comorbid disorders and drug interactions with substitution medication
    2010
  51. Nekvindova Jana; Contreras Juan Antonio; Juvan Peter; Fon Tacer Klementina; Anzenbacher Pavel; Zidek Zdenek; Kopecna Zapletalova Michaela; Rozman Damjana; Anzenbacherová Eva
    Acyclic nucleoside phosphonates
    2014
  52. Ferk Polonca; Leskošek Branimir; Kržan Mojca
    A population-based study of outpatient antipsychotic prescription trends in Slovenia - preliminary results
    2013
  53. Pal Marjetka; Ferk Polonca; Leskošek Branimir
    Ambulantno predpisovanje antihipetenzivov in kakovost nadzora arterijske hipertenzije v Sloveniji
    [Outpatient prescribing of antihypertensives and quality of arterial hypertension control in Slovenia]
    2014
  54. Knez Lea; Čufer Tanja
    Drug interactions in cancer treatment
    2013
  55. Roškar Robert
    Interakcije zdravil za zdravljenje revmatičnih bolezni
    [Interactions between drugs for treatment of rheumatic diseases]
    2013
  56. Koprivšek Jure; Čelofiga Andreja
    Psihiatrični utrinki
    2012
  57. Kores-Plesničar Blanka
    Interakcije med zdravili in ostaloimi učinkovinami
    [Interactions between drugs and other substances]
    2012
  58. Bukovnik Nejc; Mekiš Dušan; Križmarić Miljenko
    Pharmacokinetic and pharmacodynamic simulation of non-depolarizing muscle relaxant Rocuronium (Esmeron)
    2012
  59. Koprivšek Jure
    Predstavitev nekaterih računalniških aplikacij za ugotavljanje interakcij med zdravili
    [Presentations of certain computer applications for drug-drug interactions checking]
    2012
  60. Režonja Renata; Knez Lea; Čufer Tanja; Mrhar Aleš
    Oral treatment with etoposide in small cell lung cancer - dilemmas and solution
    2013
  61. Roblek T; Trobec K; Mrhar A; Lainščak M
    Drug-drug interactions in hospitalized patients with chronic heart failure
    2012
  62. Roblek T; Trobec K; Mrhar A; Lainščak M
    Drug-drug interactions in hospitalized patients with chronic obstructive pulmonary disease
    2012
  63. Šeruga Boštjan; Novak Šarotar Brigita; Knez Lea; Borštnar Simona; Janša Rado; Kocmur Marga; Čufer Tanja
    Sočasno zdravljenje s tamoksifenom in z zaviralci CYP2D6: klinični pomen interakcij zdravil
    [Concurrent treatment with tamoxifen and CYP2D6 inhibitors: clinical significance of drug interactions]
    2012
  64. Cvirn.-Novak Mateja; Čater Nataša; Urbanc Marina; Vovk Tomaž
    Lekarniški farmacevt in bolezni ušes, nosu in grla
    [Community pharmacist and diseases of ear, nose and throat]
    2012
  65. Belič Aleš; Ačimovič Jure; Naik Adviti; Goličnik Marko
    Analysis of the steady-state relations and control-algorithm characterisation in a mathematical model of cholesterol biosynthesis
    2013
  66. Brvar Miran
    Neželeni učinki in zastrupitve zaradi samozdravljenja
    [Adverse effects and poisoning due to self-medication]
    2011
  67. Monostory K; Pascussi JM; Szabo P; Temesvari M; Kohalmy K; Ačimovič J; Kocjan D; Kuzman D; Wilzewski B; Bernhardt R; Kobori L; Rozman D
    Drug interaction potential of LK-935, the novel nonstatin-type cholesterol-lowering agent
    2009
  68. Krčevski-Škvarč Nevenka
    Variability in the response to opioid therapy
    2009
  69. Režen Tadeja
    The impact of cholesterol and its metabolites on drug metabolism
    2011
  70. Premuš-Marušič Alenka; Mrhar Aleš
    Interakcije med zdravili pri bolnikih na Kirurškem oddelku Splošne bolnišnice Murska Sobota
    [Drug interactions in patients at the Surgery Department of the Murska Sobota General Hospital]
    2010
  71. Tavčar Petra; Sonc Monika; Kmetec Vojko
    Problematika visokih odmerkov metotreksata pri onkoloških bolnikih
    2010
  72. Skok Pavel; Ćeranić Davorin
    Zaviralci protonske črpalke in antiagregacijska zdravila
    [Proton pump inhibitors and antiplatelet therapy]
    2010
  73. Brvar Miran; Slana Mojca; Možina Hugon; Možina Martin
    Pregledi bolnikov v urgentnih internističnih ambulantah zaradi neželenih učinkov zdravil
    [Adverse drug reactions as a cause of admission to a medical emergency department]
    2010
  74. Fokter N; Možina M; Bunc M; Brvar M
    Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical department
    2009
  75. Modic Mojca; Sever Matjaž
    Najpogostejši medsebojni vplivi zdravil pri zdravljenju bolezni trombocitno/megakariocitne vrste
    [Common drug interactions in treatment of platelet disorders]
    2009
  76. Pretnar Jožef; Škerget Matevž
    Najpogostejši medsebojni vplivi zdrabil pri zdravljenju bolezni levkocitne vrste
    [Common drug interactions in treatment of white blood cell disorders]
    2009
  77. Černelč Peter
    Najpogostejši medsebojni vplivi zdravil pri zdravljenju bolezni levkocitne, eritrocitne in trombocitne vrste
    [Common drug interactions in the treatment of white cell, red cell and platelet disorders]
    2009
  78. Stanovnik Lovro
    Klinično pomembne interakcije med zdravili pri novorojenčkih
    [Clinical relevance of drug interactions in neonates]
    2009
  79. Fokter N; Možina M; Brvar M
    Potential drug-drug interactions in patients treated in medical departments
    2009
  80. Fokter Nina; Možina Martin; Brvar Miran
    Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments
    2009
  81. Sepčić Kristina; Perković Olivio; Turel Iztok; Sepčić Juraj
    Nuspojave i interakcije fluorokinolona
    [Adverse effects and interactions of fluoroquinolones]
    2009
  82. Petek-Šter Marija; Cedilnik-Gorup Eva; Klančič Dean
    Polifarmacija in neprimerno predpisovanje zdravil pri starostnikih v domovih starejših občanov
    [Polypharmacy and inappropriate drug prescribing in elderly nursing home residents]
    2009
  83. Fokter N; Možina M; Bunc M; Brvar M
    Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments
    2009
  84. Fokter Nina
    Pregled medsebojnega delovanja zdravil pri bolnikih na kliničnih oddelkih in centrih interne medicine Univerzitetnega kliničnega centra v Ljubljani
    2008
  85. Virant Igor; Sonc Monika; Čufer Tanja
    Farmakologija protitumornih učinkovin s poudarkom na interakcijah
    2006
  86. Kanič Vojko
    Varnost statinov
    2008
  87. Rus Primož; Rus Rina
    Koencim Q 10
    [Coenzyme Q 10]
    2008
  88. Strle Klemen; McCusker Robert H; Tran Lynn; King Alexandra; Johnson Rodney W; Freund Gregory G; Dantzer Robert; Kelley Keith W
    Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGF-I in myoblasts
    2007
  89. Szikra T; Križaj D
    The dynamic range and domain-specific signals of intracellular calcium in photoreceptors
    2006
  90. Sonc Monika
    Interakcije in nezaželeni učinki prehranskih dopolnil
    2007
  91. Čebular Boštjan; Zgonc Vid
    Posebnosti zdravljenja epilepsije pri starejših
    [Issues when treating epilepsy in the elderly]
    2007
  92. Grabnar Iztok; Locatelli Igor; Herman Darja; Peternel Polona; Stegnar Mojca; Lainščak Mitja; Breskvar Katja; Dolžan Vita; Mrhar Aleš
    Drug interactions with carbamezapine: a case study on influence on anticoagulation treatment with warfarin
    [Interakcije zdravil s karbamazepinom: primer raziskave vpliva na antikoagulacijsko zdravljenje v varfarinom]
    2007
  93. Fuhr Uwe
    CYP phenotyping to assess drug-drug interaction
    2007
  94. Benedik Miha
    Interakcije med zdravili in ledvice
    2006
  95. Vitorovič Sveto
    Součinkovanje zdravil pri starostnikih
    [Drug interactions in old age]
    2005
  96. Strgar-Hladnik Mihaela
    Migrena in depresija
    [Migraine and depression]
    2006
  97. Herman Darja; Locatelli Igor; Grabnar Iztok; Peternel Polona; Stegnar Mojca; Lainščak Mitja; Mrhar Aleš; Breskvar Katja; Dolžan Vita
    The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintance dose
    2006
  98. Gorup Eva
    Polifarmacija, varnost predpisovanja in interakcije zdravil pri sočasnih boleznih in stanjih
    2005
  99. Rotar-Pavlič Danica; Tršinar Mihaela; Milovanovič Meta; Bobnar-Najžer Elizabeta
    Varna uporaba, jemanje in shranjevanje zdravil
    2005
  100. Glavan G; Živin M
    Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats
    2005

1 101 201  


Nova poizvedba      Pripombe      Na vrh strani                        Inštitut za biostatistiko in medicinsko informatiko